Business
Is the CSL (ASX:CSL) share price too cheap to ignore?
It has been an unusually disappointing year for the CSL Limited (ASX: CSL) share price.
The biotechnology giant’s shares have thoroughly underperformed the market during this time and are trading significantly lower than their 52-week high.
In fact, with the CSL share price currently fetching $263.40, it is down 21% from its high of $332.68.
Why is the CSL share price under pressure?
The weakness in the CSL share price has been driven largely by concerns over plasma collection headwinds.
As well as being impacted by social distancing initiatives, COVID stimulus payments have prevented some traditional donors from donating. This has led to a reduction in supply and an increase in costs.
Given how plasma is a vital component in…
-
General17 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News16 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General18 hours agoThailand punches above its weight in film creativity and cross-border appeal. Here’s why
-
General11 hours agoAFL Round 18 live updates: Bulldogs vs Crows, Giants vs Cats, Tigers vs Bombers, Dockers vs Hawks — blog, scores and stats